MATTHEW RISENDAL
Allopathic & Osteopathic Physicians|Urology FISHERSVILLE, VA NPI 1669904488
Browse related groups: Allopathic & Osteopathic Physicians|Urology VA PFIZER INC. All categories
General Payments — all program years on this page
$3,716.97
- Category: General Payments
- Program years: PY2021–2024
- Record count: 128
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,262.71 across 43 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,242.74 | 42 |
| Entertainment | $19.97 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $185.01 | 8 |
| PROCEPT BioRobotics Corporation | $137.33 | 1 |
| Sumitomo Pharma America, Inc. | $135.19 | 5 |
| ABBVIE INC. | $121.19 | 5 |
| ACCORD HEALTHCARE, INC. | $101.61 | 3 |
| BOSTON SCIENTIFIC CORPORATION | $97.90 | 1 |
| Axonics Modulation Technologies, Inc. | $64.19 | 3 |
| Astellas Pharma US Inc | $54.29 | 2 |
| UROGEN PHARMA, INC. | $50.62 | 2 |
| Laborie Medical Technologies Corp. | $43.14 | 1 |
| Ambu Inc. | $41.99 | 2 |
| Janssen Biotech, Inc. | $30.83 | 1 |
| C. R. BARD, INC. & SUBSIDIARIES | $29.45 | 1 |
| Tempus AI, Inc | $29.27 | 1 |
| Antares Pharma, Inc. | $25.02 | 1 |
| Endo Pharmaceuticals Inc. | $24.30 | 1 |
| Calyxo, Inc. | $20.51 | 1 |
| Provepharm Inc. | $19.97 | 1 |
| Endo USA, Inc. | $18.33 | 1 |
| IMMUNITYBIO, INC. | $16.32 | 1 |
| Ferring Pharmaceuticals Inc. | $16.25 | 1 |
By program year
Records — PY2024 (43)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.